Perceptive Discovery Launches Astatine-211 Study Capabilities in the US and UK

PartnershipAstatine-211Positive

AI Analysis

Summary

Perceptive Discovery announced it has launched Astatine-211 study capabilities in the US and UK, becoming the first US provider able to support At-211 studies via its collaboration with Atley Solutions.

Outcome Details

Perceptive Discovery announced it is the first US provider able to support At-211 studies in the US and UK, through collaboration with Atley Solutions.

Importance:4/10

Sentiment:

0.40

radiopharmaceuticalastatine-211CROpartnershiptargeted alpha therapypreclinical services

Related Companies

$TRAX

Read the original article

Published by PR Newswire Clinical Trials on October 16, 2026 10:04 AM

Read Original